Dr. Moons Anke
Dr. Moons Anke has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €19k and a net result of €184k. The figures fluctuate too strongly year-on-year for a reliable trend projection. The computed 12-month bankruptcy probability is 1.1% (low).
| Equity | €19k |
| Net result | €184k |
| Active | 8 yrs |
| Locations | 1 |
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €248k | €169k | €171k | €140k | €105k |
| Net profit | €184k | €126k | €132k | €102k | €81k |
| Cash flow | €188k | €129k | €134k | €105k | €84k |
| Staff costs | - | - | - | - | - |
| Income taxes | €62k | €42k | €36k | €35k | €21k |
| Dividends | €184k | €126k | €493k | - | - |
| Total assets | €375k | €388k | €377k | €388k | €283k |
| Equity | €19k | €19k | €19k | €380k | €272k |
| Debt | €356k | €370k | €359k | €8k | €12k |
| of which ≤ 1y | €356k | €369k | €359k | €8k | €12k |
| of which > 1y | - | - | - | - | - |
| Working capital | €2k | €3k | €-368 | €365k | €263k |
| Employees (FTE) | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 1.01 | 1.01 | 1.00 | 48.00 | 23.69 |
| Quick ratio | 1.01 | 1.01 | 1.00 | 48.00 | 23.69 |
| Working capital ratio | 0.6% | 0.8% | -0.1% | 94.1% | 92.7% |
| Solvency | 5.0% | 4.8% | 4.9% | 98.0% | 95.9% |
| Debt / equity | 19.17 | 19.87 | 19.28 | 0.02 | 0.04 |
| Long-term debt ratio | - | - | - | - | - |
| Interest coverage | 236.98 | 137.54 | 264.09 | 142.27 | 505.73 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 48.9% | 32.3% | 34.9% | 26.4% | 28.6% |
| ROE | 986.6% | 674.8% | 708.5% | 26.9% | 29.8% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Full annual accounts (23 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €375k | €388k | €377k | €388k | €283k |
| Fixed assets | 21/28 | €17k | €16k | €19k | €15k | €9k |
| Tangible fixed assets | 22/27 | €9k | €7k | €11k | €7k | €6k |
| Financial fixed assets | 28 | €8k | €8k | €8k | €8k | €3k |
| Current assets | 29/58 | €358k | €372k | €358k | €373k | €274k |
| Amounts receivable within one year | 40/41 | - | - | €37k | €36k | €6k |
| Cash & bank | 54/58 | €317k | €352k | €318k | €319k | €268k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €375k | €388k | €377k | €388k | €283k |
| Equity | 10/15 | €19k | €19k | €19k | €380k | €272k |
| Contributions / capital | 10/11 | €19k | €19k | €19k | €19k | €12k |
| Reserves | 13 | - | - | - | €362k | €178k |
| Accumulated profits (losses) | 14 | - | - | - | - | €81k |
| Amounts payable | 17/49 | €356k | €370k | €359k | €8k | €12k |
| Amounts payable within one year | 42/48 | €356k | €369k | €359k | €8k | €12k |
| Trade debts payable within one year | 44 | €891 | €926 | €722 | €81 | €171 |
| Income statement | ||||||
| Gross operating margin | 9900 | €249k | €170k | €171k | €141k | €106k |
| Operating result | 9901 | €244k | €166k | €168k | €138k | €102k |
| Financial income | 75 | €3k | €3k | €0 | €3 | €3 |
| Financial charges | 65 | €1k | €1k | €646 | €986 | €208 |
| Result before taxes | 9903 | €246k | €168k | €167k | €137k | €102k |
| Income taxes | 67/77 | €62k | €42k | €36k | €35k | €21k |
| Net result for the period | 9904 | €184k | €126k | €132k | €102k | €81k |
| Result to be appropriated | 9905 | €184k | €126k | €132k | €102k | €81k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 28-08-2018 |
| Status | Active |
| Postal code | 3550 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71029B0490/00D000 | Flanders | 3,056 m² | 1 · 286 m² | 7.1 m · 2 fl. |
| 71025A1561/00M003 | Flanders | 963 m² | 1 · 123 m² | 15.4 m · 2 fl. |
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
| Legal nameNL | Dr. Moons Anke |